SCHEDULE Filed 2025-11-12 Event 2025-11-10 SEC 0001193125-25-277603 →

Versant Venture Capital VI, L.P. → Monte Rosa Therapeutics, Inc. GLUE

Stake: 5.10% Shares: 3,334,669 CUSIP: 61225M102 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

15 filings by this filer

14 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 13.08

17,195,471 shares short · -7.7% vs prior

Post-Filing Returns · since 2025-11-10 on GLUE

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

0.0%

+90 days

0.0%

+180 days

0.0%

Anchor price 24.40 on closest trading day on/after 2025-11-10. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Monte Rosa Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-07-06	SCHEDULE 13D/A	New Enterprise Associates 17, L.P.	—	6,692,298	view →
2026-01-09	SCHEDULE	Versant Venture Capital VI, L.P.	3.40%	2,236,708	view →

Other Filings by Versant Venture Capital VI, L.P.

Filed	Form	Issuer	Stake	Shares
2026-01-09	SCHEDULE	Monte Rosa Therapeutics, Inc. GLUE	3.40%	2,236,708	view →
2025-09-23	SCHEDULE	LAVA Therapeutics NV	—	—	view →
2025-08-13	SCHEDULE	Tempest Therapeutics, Inc. TPST	3.70%	162,972	view →
2025-02-11	SCHEDULE	Tempest Therapeutics, Inc. TPST	4.80%	2,118,644	view →
2022-01-13	SC	Oyster Point Pharma, Inc.	—	—	view →
2021-10-27	SC	Oyster Point Pharma, Inc.	—	—	view →
2021-06-21	SC	Aligos Therapeutics, Inc. ALGS	—	—	view →
2021-05-24	SC	Oyster Point Pharma, Inc.	—	—	view →
2021-05-03	SC	Aligos Therapeutics, Inc. ALGS	—	—	view →
2021-04-05	SC	Oyster Point Pharma, Inc.	—	—	view →
2021-03-01	SC	Oyster Point Pharma, Inc.	—	—	view →
2020-12-03	SC	Black Diamond Therapeutics, Inc. BDTX	—	—	view →
2020-11-23	SC	Black Diamond Therapeutics, Inc. BDTX	—	—	view →
2020-09-25	SC	Black Diamond Therapeutics, Inc. BDTX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →